This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Centene reported first-quarter net earnings of $1.5 billion, raised full-year profit guidance, and posted adjusted EPS of $3.37 despite a drop in ACA marketplace membership from 5.6 million to 3.6 million. Revenue rose to $49.9 billion from $46.6 billion as premium increases offset the member decline, though the 75.3% commercial Health Benefit Ratio signals a sicker remaining pool. The article frames the broader ACA market as benefiting insurers through higher pricing and risk adjustment, but at the expense of consumers' out-of-pocket costs.

Analysis

The market is rewarding carrier discipline, but the real winner is the pricing power embedded in a shrinking risk pool. If the post-subsidy enrollment reset persists, the next leg is not just margin expansion for CNC/UNH/ELV; it is a transfer of economics from consumers to insurers via better mix and stronger risk-adjustment receipts. The second-order effect is that the ACA exchanges may become less of a volume game and more of a state-by-state oligopoly where the few carriers willing to tolerate volatility can reprice faster than members can shop around.

The near-term risk is that today’s earnings strength bakes in a false sense of stability. High-acuity retention helps near-term medical trend math, but it also raises the probability of outsized utilization surprises in 2H26 if deferred care normalizes or if claims catch-up from sicker cohorts accelerates. That creates a classic lagged earnings trap: results look clean for 1-2 quarters, then medical cost ratios reaccelerate once the new premium base has already been set.

Consensus is likely underestimating how asymmetric this is across carriers. CNC has the most direct exposure to ACA mix and therefore the clearest operating leverage to both good and bad selection; UNH and ELV have more diversified buffers, so they are better positioned if exchange volatility spills into Medicaid/MA pricing discipline, but they also have less torque to the upside from the current dislocation. The underappreciated bull case is that a smaller marketplace with better pricing can support durable margins for years, even if unit growth never comes back.

The contrarian risk is political: sustained household pain raises the odds of regulatory intervention, subsidy extension, or state-level affordability actions within the next 6-12 months. That would compress carrier pricing freedom and could quickly unwind the current rerating if investors are extrapolating 2026 rates too aggressively. The setup favors owning the diversified winners while being more selective on the pure-play exchange beneficiary.

Key Decisions for Investors

• Long UNH / short CNC, 3-6 months: favor the diversified earnings base and lower single-line ACA exposure; this pair captures upside if managed-care margins stay firm but protects against a late-2026 exchange reversal.
• Buy CNC on pullbacks only, with a 2-4 quarter horizon: the stock should remain tactically supported by pricing discipline, but position size should be capped given the highest sensitivity to subsidy-policy headlines and membership volatility.
• Sell downside skew via ELV put spreads 4-6 months out: the market is rewarding execution, but ELV’s more balanced book should limit downside if exchange shrinkage worsens; risk/reward favors harvesting elevated implied volatility rather than outright shorting.
• Long a basket of managed care leaders vs. ACA policy proxies, 6-12 months: pair CNC/UNH/ELV long against consumer-affordability-sensitive retail names or exchange brokers if subsidy fatigue becomes a macro theme; the spread benefits from continued premium inflation and unfavorable consumer optics.
• Reduce or avoid outright short exposure until policy risk is priced: the trend can persist for several quarters, and the first catalyst for reversal is likely legislative rather than fundamental, making timing on shorts poor versus buying protection.